Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.8B | 6.8B | 7.2B | 6.8B |
| Cost of revenue | 4.3B | 4.4B | 4.4B | 4.3B |
| Gross profit | 2.5B | 2.3B | 2.7B | 2.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 267M | 276M | 268M | 259M |
| Other operating expenses | 447M | 562M | 391M | 427M |
| Operating income | 1.5B | 1.2B | 1.8B | 1.6B |
| Non operating interest income | ||||
| Income | 59M | 41M | 60M | 34M |
| Expense | 318M | 327M | 312M | 252M |
| Other income expense | 114M | -1.1B | 17M | 256M |
| Pretax income | 1.3B | -169M | 1.6B | 1.6B |
| Tax provision | 387M | -49M | 454M | 465M |
| Net income | 945M | -120M | 1.1B | 1.2B |
| Basic EPS | 0.2 | -0.1 | 0.3 | 0.3 |
| Diluted EPS | 0.2 | -0.1 | 0.3 | 0.3 |
| Basic average shares | 2.2B | 2.2B | 2.2B | 2.1B |
| Diluted average shares | 2.3B | 2.2B | 2.3B | 2.3B |
| EBITDA | 3.6B | 3.4B | 4.0B | 3.6B |
| Net income from continuing op. | 945M | -120M | 1.1B | 1.2B |
| Minority interests | -9M | -7M | -7M | -8M |
| Preferred stock dividends | 5M | -2M | 5M | 7M |